| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.4 |